Literature DB >> 24327237

Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective.

Kris M Jamsen1, Sarah C McLeay, Michael A Barras, Bruce Green.   

Abstract

The key purpose of performing pharmacometric research is to aid optimization of drug dosing strategies. The statistical techniques required for this research are advanced, which can make interpretation of results difficult to convey to the target audience if they are unfamiliar with pharmacometric concepts. This article provides a basic guide for authors who wish to publish pharmacometric analyses in peer-reviewed journals. This guide is intended to enhance the readability, reproducibility and understanding of the work for a general readership, which may include clinicians, pharmacists and pharmacometricians. Presentation techniques and examples are offered, as well as a checklist of suggested contents for the manuscript.

Mesh:

Year:  2014        PMID: 24327237     DOI: 10.1007/s40262-013-0114-1

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  21 in total

1.  A guide to write a scientific paper for new writers.

Authors:  Pao-Yuan Lin; Ur-Ren Kuo
Journal:  Microsurgery       Date:  2011-11-28       Impact factor: 2.425

2.  Critical appraisal of published research: introductory guidelines.

Authors:  F G Fowkes; P M Fulton
Journal:  BMJ       Date:  1991-05-11

3.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

Review 4.  How to critically appraise an article.

Authors:  Jane M Young; Michael J Solomon
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-01-20

Review 5.  Review article: A primer for clinical researchers in the emergency department: Part III: How to write a scientific paper.

Authors:  Andrew Davidson; David McD Taylor; Franz E Babl
Journal:  Emerg Med Australas       Date:  2012-04-25       Impact factor: 2.151

Review 6.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

Review 7.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  BMJ       Date:  2003-01-04

8.  Basic concepts in population modeling, simulation, and model-based drug development.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-09-26

9.  Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-04-17

10.  A time to event tutorial for pharmacometricians.

Authors:  Nick Holford
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-05-15
View more
  13 in total

1.  Impact of Demographics, Organ Impairment, Disease, Formulation, and Food on the Pharmacokinetics of the Selective S1P1 Receptor Modulator Ponesimod Based on 13 Clinical Studies.

Authors:  Dominik Lott; Thorsten Lehr; Jasper Dingemanse; Andreas Krause
Journal:  Clin Pharmacokinet       Date:  2017-04       Impact factor: 6.447

Review 2.  Reproducible pharmacokinetics.

Authors:  John P A Ioannidis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-04-19       Impact factor: 2.745

3.  Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations.

Authors:  Yu Cheng; Chen-Yu Wang; Zi-Ran Li; Yan Pan; Mao-Bai Liu; Zheng Jiao
Journal:  Clin Pharmacokinet       Date:  2021-01       Impact factor: 6.447

4.  Evaluation of Assumptions Underpinning Pharmacometric Models.

Authors:  Qing-Xi Ooi; Daniel F B Wright; Geoffrey K Isbister; Stephen B Duffull
Journal:  AAPS J       Date:  2019-08-05       Impact factor: 4.009

5.  Pharmacokinetics of sildenafil in children with pulmonary arterial hypertension.

Authors:  Hugo Juárez Olguín; Hector Osnaya Martínez; Carmen Flores Pérez; Blanca Ramírez Mendiola; Liliana Rivera Espinosa; Juan Luis Chávez Pacheco; Janett Flores Pérez; Ignacio Mora Magaña
Journal:  World J Pediatr       Date:  2017-08-08       Impact factor: 2.764

6.  Application of a Physiologically Based Pharmacokinetic Model to Predict Cefazolin and Cefuroxime Disposition in Obese Pregnant Women Undergoing Caesarean Section.

Authors:  Hanadi H Alrammaal; Khaled Abduljalil; Victoria Hodgetts Morton; R Katie Morris; John F Marriott; Hsu P Chong; Hannah K Batchelor
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

Review 7.  Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.

Authors:  Marko A Peltoniemi; Nora M Hagelberg; Klaus T Olkkola; Teijo I Saari
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

8.  Modelling pharmacokinetics and pharmacodynamics of the selective S1P1 receptor modulator cenerimod in healthy subjects and systemic lupus erythematosus patients.

Authors:  Dominik Lott; Pierre-Eric Juif; Jasper Dingemanse; Andreas Krause
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

Review 9.  Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities?

Authors:  Olivia Campagne; Donald E Mager; Kathleen M Tornatore
Journal:  J Clin Pharmacol       Date:  2018-10-29       Impact factor: 3.126

10.  Reporting guidelines for population pharmacokinetic analyses.

Authors:  Kevin Dykstra; Nitin Mehrotra; Christoffer Wenzel Tornøe; Helen Kastrissios; Bela Patel; Nidal Al-Huniti; Pravin Jadhav; Yaning Wang; Wonkyung Byon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-04-30       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.